AMN:NYE-AMN Healthcare Services Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 96.65

Change

-2.98 (-2.99)%

Market Cap

USD 5.12B

Volume

1.12M

Avg Analyst Target

USD 125.20 (+29.54%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

AMN Healthcare Services Inc (AMN) Stock Analysis:
Based on the AMN Healthcare Services Inc stock forecasts from 3 analysts, the average analyst target price for AMN Healthcare Services Inc is USD 125.20 over the next 12 months. AMN Healthcare Services Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AMN Healthcare Services Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, AMN Healthcare Services Inc’s stock price was USD 96.65. AMN Healthcare Services Inc’s stock price has changed by -9.69% over the past week, -23.21% over the past month and +32.27% over the last year.

About

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. The company operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and ...Read More

Company Website : https://www.amnhealthcare.com

Address : 8840 Cypress Waters Boulevard, Dallas, TX, United States, 75019

Employees : 3,000

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.27

52 Week High : 129.12

Short Ratio : 2.58

52 Week Low : 69.50

Shorted Shares : 1,048,838

200 Day Moving Average : 102.08

Shorted Shares Previous Month : 965,261

50 Day Moving Average : 113.83

Shares Held By Insiders : 0.82%

Short Percentage : 3.03%

Shares Held by Institutions : 97.40%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-20 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare Inc

-4.57 (-1.86%)

 USD76.30B 12.56 8.20
FMS Fresenius Medical Care AG & Co..

-0.30 (-0.89%)

 USD19.81B 18.90 8.41
DVA DaVita Inc

-0.23 (-0.21%)

 USD11.23B 12.87 8.80
UHS Universal Health Services Inc

-1.43 (-1.10%)

 USD10.40B 10.42 7.08
THC Tenet Healthcare Corporation

+1.25 (+1.62%)

 USD8.27B 7.80 5.16
CHE Chemed Corporation

-4.12 (-0.87%)

 USD7.37B 25.13 17.40
AGL agilon health inc

+0.16 (+0.95%)

 USD6.65B N/A N/A
EHC Encompass Health Corporation

+0.68 (+1.11%)

 USD6.55B 22.24 8.94
OSH Oak Street Health Inc

-0.38 (-1.95%)

 USD5.30B N/A N/A
SEM Select Medical Holdings Corpor..

-0.50 (-2.08%)

 USD3.22B 7.53 7.34

ETFs Containing AMN

Symbol Name Weight Mer Price(Change) Market Cap
IJR iShares Core S&P Small-Ca.. 0.00 % 0.06 %

-2.30 (-2.12%)

 USD75.59B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

-1.46 (-0.93%)

 USD0.48B
SAA ProShares Trust - ProShar.. 0.00 % 0.95 %

-1.24 (-4.24%)

 USD0.04B
SLY SPDR Series Trust - SPDR .. 0.00 % 0.15 %

-1.99 (-2.11%)

 USD1.85B
HERS:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

 USD3.37M
HERS-B:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

 N/A
SMLE DBX ETF Trust - S&P Small.. 0.00 % 0.15 %

-0.59 (-2.25%)

 N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.99% 18% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.99% 18% F 4% F
Trailing 12 Months  
Capital Gain 32.27% 84% B 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.27% 84% B 84% B
Trailing 5 Years  
Capital Gain 161.22% 79% C+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 161.22% 79% C+ 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 28.43% 74% C 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.43% 74% C 86% B
Risk Return Profile  
Volatility (Standard Deviation) 37.17% 47% F 29% F
Risk Adjusted Return 76.50% 89% B+ 80% B-
Market Capitalization 5.12B 59% F 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 45.61 17% F 15% F
Price/Book Ratio 5.04 44% F 19% F
Price / Cash Flow Ratio 19.94 5% F 24% F
EV/EBITDA 13.68 29% F 44% F
Management Effectiveness  
Return on Equity 2,384.14% 95% A 97% A+
Return on Invested Capital 8.46% 55% F 69% D+
Return on Assets 8.55% 90% A- 88% B+
Debt to Equity Ratio 104.67% 59% F 34% F
Technical Ratios  
Short Ratio 2.58 64% D 38% F
Short Percent 3.03% 64% D 50% F
Beta 0.27 89% B+ 89% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector